On April 12, 2021 Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, APR 12, 2021, View Source [SID1234577933]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

– SmallCap Event – Digital event
14 & 15 April 2021

– KEMPEN LIFE SCIENCES CONFERENCE – 2021 Thematic Virtual Series
21 April 2021 – Immuno and Targeted Oncology

– Spring European Midcap Event – Digital event
22 & 23 June 2021